Revvity ROE 2010-2024 | RVTY

Current and historical return on equity (ROE) values for Revvity (RVTY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Revvity ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.15B $7.85B 1.92%
2023-12-31 $0.69B $7.87B 8.81%
2023-09-30 $0.74B $7.69B 9.58%
2023-06-30 $0.82B $7.87B 10.78%
2023-03-31 $0.96B $8.03B 12.97%
2022-12-31 $0.57B $7.38B 7.90%
2022-09-30 $0.63B $7.07B 8.84%
2022-06-30 $0.67B $7.17B 9.48%
2022-03-31 $0.74B $7.19B 11.61%
2021-12-31 $0.94B $7.14B 16.88%
2021-09-30 $1.13B $6.96B 23.93%
2021-06-30 $1.18B $4.24B 31.09%
2021-03-31 $1.07B $4.00B 30.80%
2020-12-31 $0.73B $3.74B 22.94%
2020-09-30 $0.41B $3.23B 14.03%
2020-06-30 $0.30B $2.97B 10.49%
2020-03-31 $0.23B $2.76B 8.26%
2019-12-31 $0.23B $2.81B 8.39%
2019-09-30 $0.23B $2.71B 8.80%
2019-06-30 $0.25B $2.71B 9.60%
2019-03-31 $0.25B $2.64B 9.58%
2018-12-31 $0.24B $2.59B 9.31%
2018-09-30 $0.13B $2.57B 4.97%
2018-06-30 $0.14B $2.52B 5.54%
2018-03-31 $0.28B $2.56B 11.16%
2017-12-31 $0.29B $2.50B 12.10%
2017-09-30 $0.40B $2.54B 17.09%
2017-06-30 $0.37B $2.44B 16.38%
2017-03-31 $0.23B $2.21B 10.53%
2016-12-31 $0.23B $2.15B 11.11%
2016-09-30 $0.24B $2.14B 11.31%
2016-06-30 $0.23B $2.09B 11.28%
2016-03-31 $0.22B $2.05B 10.51%
2015-12-31 $0.21B $2.11B 10.16%
2015-09-30 $0.18B $2.05B 8.46%
2015-06-30 $0.16B $2.12B 7.82%
2015-03-31 $0.16B $2.06B 7.93%
2014-12-31 $0.16B $2.04B 7.67%
2014-09-30 $0.19B $2.06B 9.48%
2014-06-30 $0.19B $2.06B 9.55%
2014-03-31 $0.17B $2.03B 8.66%
2013-12-31 $0.17B $1.99B 8.78%
2013-09-30 $0.08B $1.92B 4.45%
2013-06-30 $0.07B $1.86B 3.91%
2013-03-31 $0.08B $1.83B 4.21%
2012-12-31 $0.07B $1.94B 3.71%
2012-09-30 $0.00B $1.94B 0.16%
2012-06-30 $0.01B $1.89B 0.53%
2012-03-31 $0.01B $1.88B 0.31%
2011-12-31 $0.01B $1.84B 0.42%
2011-09-30 $0.39B $1.95B 20.07%
2011-06-30 $0.36B $1.96B 19.42%
2011-03-31 $0.39B $1.91B 21.83%
2010-12-31 $0.39B $1.93B 22.64%
2010-09-30 $0.13B $1.71B 7.93%
2010-06-30 $0.13B $1.64B 8.12%
2010-03-31 $0.10B $1.63B 5.97%
2009-12-31 $0.08B $1.63B 5.26%
Sector Industry Market Cap Revenue
Medical Medical Services $13.772B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
Cencora (COR) United States $45.072B 17.57
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Viatris (VTRS) United States $13.931B 4.16
Natera (NTRA) United States $13.029B 0.00
Medpace Holdings (MEDP) United States $11.839B 35.92
Charles River Laboratories (CRL) United States $11.456B 21.93
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
CareDx (CDNA) United States $0.959B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00